Large-scale testing (Phase 3)Study completedNCT00337285
What this trial is testing
An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Who this might be right for
Attention Deficit Hyperactivity DisorderAttention Deficit Disorders With HyperactivityAttention Deficit Hyperactivity Disorders
New River Pharmaceuticals 349